Stay updated on INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial

Sign up to get notified when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A banner announces an NIH-wide transition from the term “Artificial Intelligence” to “Super Intelligence.” The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:53:28.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T22:56:21.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study details and indicating restricted access to the record.
    Difference
    18%
    Check dated 2026-09-22T23:11:25.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.6 to v3.7.0, indicating a newer page revision. This typically reflects maintenance or minor improvements rather than changes to study data or content.
    Difference
    0.0%
    Check dated 2026-09-15T21:46:12.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page's revision tag updated from v3.6.5 to v3.6.6. This reflects a minor platform update rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-09-01T18:29:13.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added a new funding entry: 2017 NIH grant/contract appears in the funding section, clarifying an additional source of support for the study.
    Difference
    0.0%
    Check dated 2026-08-25T19:56:10.000Z thumbnail image

Stay in the know with updates to INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.